Paul Kent

553 total citations
52 papers, 336 citations indexed

About

Paul Kent is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Paul Kent has authored 52 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 11 papers in Oncology. Recurrent topics in Paul Kent's work include Sarcoma Diagnosis and Treatment (17 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Paul Kent is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Paul Kent collaborates with scholars based in United States, Australia and Switzerland. Paul Kent's co-authors include Howard M. Katzenstein, Wendy B. London, Susan L. Cohn, Susan Wojcik, William E. Grant, Jennifer A. Coleman, Hale M. Thompson, Robert E. Kimura, Jacques S. Abramowicz and Sharon E. Byrd and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Molecular Cancer.

In The Last Decade

Paul Kent

46 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Kent United States 11 85 81 65 60 43 52 336
Jochen Roessler Switzerland 9 43 0.5× 42 0.5× 79 1.2× 37 0.6× 18 0.4× 21 304
Luca Bergamaschi Italy 13 167 2.0× 63 0.8× 58 0.9× 138 2.3× 57 1.3× 60 470
Michael van Trotsenburg Austria 14 37 0.4× 58 0.7× 85 1.3× 39 0.7× 124 2.9× 18 819
Elizabeth Hsu Canada 13 121 1.4× 59 0.7× 95 1.5× 134 2.2× 148 3.4× 27 565
WK Wong Australia 12 32 0.4× 42 0.5× 64 1.0× 67 1.1× 36 0.8× 19 308
Karen Damgaard-Pedersen Denmark 8 107 1.3× 34 0.4× 98 1.5× 26 0.4× 27 0.6× 16 425
Daniel David Australia 11 89 1.0× 47 0.6× 77 1.2× 16 0.3× 37 0.9× 29 588
B Anandh India 9 41 0.5× 48 0.6× 48 0.7× 51 0.8× 49 1.1× 24 306
Tina Nørgaard Munch Denmark 12 39 0.5× 160 2.0× 72 1.1× 127 2.1× 59 1.4× 36 504
Catherine L. Miller United States 13 85 1.0× 78 1.0× 91 1.4× 8 0.1× 25 0.6× 25 393

Countries citing papers authored by Paul Kent

Since Specialization
Citations

This map shows the geographic impact of Paul Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Kent more than expected).

Fields of papers citing papers by Paul Kent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Kent. The network helps show where Paul Kent may publish in the future.

Co-authorship network of co-authors of Paul Kent

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Kent. A scholar is included among the top collaborators of Paul Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Kent. Paul Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kent, Paul, Abhinav Humar, Oliver M. Fisher, et al.. (2024). Lenvatinib, gemcitabine, and oxaliplatin for 67 patients with fibrolamellar carcinoma.. Journal of Clinical Oncology. 42(16_suppl). e16151–e16151.
2.
Kent, Paul, Erik Schadde, Oliver M. Fisher, et al.. (2023). First report of tumor-informed circulating tumor DNA in fibrolamellar carcinoma in adolescents and young adults: 51 patients.. Journal of Clinical Oncology. 41(16_suppl). 3034–3034.
3.
4.
Thompson, Hale M., et al.. (2019). Evaluation of a gender-affirming healthcare curriculum for second-year medical students. Postgraduate Medical Journal. 96(1139). 515–519. 12 indexed citations
5.
Mittal, Nupur, Paul Kent, John G. Quigley, et al.. (2019). A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities. Journal of Adolescent and Young Adult Oncology. 8(3). 227–235. 8 indexed citations
6.
Kent, Paul, et al.. (2019). Radiation Exposure in Pediatric Sarcoma Patients Receiving Initial Curative Chemotherapy. Journal of Pediatric Hematology/Oncology. 42(1). e7–e11. 3 indexed citations
7.
Thompson, Hale M., Jennifer A. Coleman, & Paul Kent. (2018). LGBT Medical Education: First-Year Medical Students’ Self-Assessed Knowledge and Comfort with Transgender and LGB Populations. Medical Science Educator. 28(4). 693–697. 10 indexed citations
8.
Hogan, Patrick, et al.. (2017). Giant epidermal inclusion cyst masquerading as a soft tissue sarcoma. Journal of Pediatric Surgery Case Reports. 29. 74–77.
9.
Johnson, Angela, et al.. (2015). The Use of Acupuncture for Pain Management in Pediatric Patients: A Single-Arm Feasibility Study. Alternative and Complementary Therapies. 21(6). 255–260. 6 indexed citations
10.
Cipriano, Cara A., et al.. (2015). The Clinical Significance of Initial Pulmonary Micronodules in Young Sarcoma Patients. Journal of Pediatric Hematology/Oncology. 37(7). 548–553. 16 indexed citations
11.
Kent, Paul, et al.. (2015). Rapid Diagnosis of Nonconvulsive Status Epilepticus Using Reduced-Lead Electroencephalography. Western Journal of Emergency Medicine. 16(3). 442–446. 25 indexed citations
12.
Mueller, Emily L., et al.. (2014). Family Refusal of Chemotherapy for Pediatric Cancer Patients. Journal of Pediatric Hematology/Oncology. 37(5). 351–355. 9 indexed citations
13.
Kent, Paul, et al.. (2014). Metastatic Osteosarcoma to the Interventricular Septum: An Unusual Presentation in a Child. Pediatric Cardiology. 35(7). 1304–1305. 2 indexed citations
14.
Fricchione, Marielle, et al.. (2013). Life-threatening Paraneoplastic Syndrome in a Child With Sarcoma of the Liver Cured by Emergency Resection. Journal of Pediatric Hematology/Oncology. 35(2). 153–155. 4 indexed citations
15.
Meyer, John A., et al.. (2013). The role of imaging of malignant bone tumors in children and young adults. Current Problems in Cancer. 37(4). 181–191. 7 indexed citations
16.
Madrid, Andrés Morales La, Karen Ouyang, Gordana Raca, et al.. (2012). Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression. Pediatric Blood & Cancer. 60(2). 332–335. 3 indexed citations
17.
Byrd, Sharon E., et al.. (2011). Fetal MR imaging of posterior intracranial dural sinus thrombosis: a report of three cases with variable outcomes. Pediatric Radiology. 42(5). 536–543. 21 indexed citations
18.
Kent, Paul, Murad Alam, Amy S. Paller, et al.. (2009). GLI1 genotypes do not predict basal cell carcinoma risk: a case control study. Molecular Cancer. 8(1). 113–113. 2 indexed citations
19.
Fasano, Ross M., Paul Kent, & Leonard A. Valentino. (2005). Superior Vena Cava Thrombus Treated With Low-Dose, Peripherally Administered Recombinant Tissue Plasminogen Activator in a Child. Journal of Pediatric Hematology/Oncology. 27(12). 692–695. 8 indexed citations
20.
Katzenstein, Howard M., Paul Kent, Wendy B. London, & Susan L. Cohn. (2001). Treatment and Outcome of 83 Children With Intraspinal Neuroblastoma: The Pediatric Oncology Group Experience. Journal of Clinical Oncology. 19(4). 1047–1055. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochen Roessler Breakdown of academic impact, for papers by Luca Bergamaschi Breakdown of academic impact, for papers by Michael van Trotsenburg Breakdown of academic impact, for papers by Elizabeth Hsu Breakdown of academic impact, for papers by WK Wong Breakdown of academic impact, for papers by Karen Damgaard-Pedersen Breakdown of academic impact, for papers by Daniel David Breakdown of academic impact, for papers by B Anandh Breakdown of academic impact, for papers by Tina Nørgaard Munch Breakdown of academic impact, for papers by Catherine L. Miller
Rankless by CCL
2026